In eget turpis eget urna molestie ultricies in sagittis nunc. Sed accumsan leo in mauris rhoncus volutpat. Sed magna sapien, euismod convallis sagittis quis, varius sit amet mauris. Vivamus id quam congue venenatis et at lorem. Ut ullamcorper odio id metus eleifend tincidunt. Proin ante arcu, aliquam nec rhoncus sit amet, consequat vitae lorem. Ellentesque mollis laoreet laoreet. Nulla ut nulla sed mauris tempor pulvinar. Morbi quis nulla sit amet mi vestibulum vehicula. Pellentesque lectus metus, gravida ac sollicitudin at, ornare vel justo. Sed id arcu ac ligula malesuada accumsan.
Vivamus risus ipsum, vestibulum ut pellentesque iaculis, tempus vitae eros. Aliquam in orci non ipsum eleifend scelerisque ac id urna. Etiam tristique egestas mauris eu fringilla. Phasellus ac neque a orci mattis tincidunt eget eget ante. Maecenas placerat sapien quis purus scelerisque sed porta urna vehicula. Sed eros turpis, bibendum non ullamcorper at, euismod in nulla. Morbi eleifend sodales risus. Maecenas eu nisl ut ante dictum scelerisque. Quisque quis tempus metus. Donec sit amet diam leo, non fermentum leo. Quisque eget nulla tortor, sed vestibulum nisl.
Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas.
26. Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, Lombardi G.
Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced
pregnancy. Cabergoline and cardiac valve disease in prolactinoma patients:
additional studies during long-term treatment are required.
34. Jones J, Bashir T, Olney J, Wheatley T. Cabergoline treatment
for a large macroprolactinoma throughout pregnancy. Successful treatment
of a large macroprolactinoma with cabergoline during pregnancy.
40. Laloi-Michelin M, Ciraru-Vigneron N, Meas T.
Cabergoline treatment of pregnant women with macroprolactinomas.
31. Konopka P, Raymond JP, Merceron RE, Seneze J.
Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas.
19. Colao A, Di Sarno A, Guerra E, De Leo M, Mentone A, Lombardi G.
Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women. https://vibs.me/g1-libid-xtreme-funciona-anvisa-composicao-preco-valor-comprar-resenha-farmacia-bula-reclame-aqui-saiba-tudo-2024/